Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole 5mg vs 10mg for Ovarian Stimulation in PCOS
NCT07448272Active, not recruiting
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of letrozole in polycystic ovary syndrome (PCOS) and infertility (2 arms). Primary endpoints: Presence of preovulatory follicle at 12 weeks and Multifollicular development at 12 weeks. Started Apr 2025; status: active, not recruiting.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on NCT07448272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07448272.